Poster
07-01-2004, 10:14 AM
Eli Lilly, along with partner Amylin Pharmaceuticals, have applied for regulatory approval from the FDA for a new drug called exenatide. The drug originates from the saliva of gila monsters and helps to stabilize blood sugar levels of diabetics. This could be the first drug designed for type 2 diabetes, or adult-onset diabetes, which does not require the use of insulin injections. Pills are normally given to patients with type 2 diabetes, but they often fail to regulate blood sugar adequately and frequently result in weight gain. Those taking exenatide in trial sessions lost weight, with an average of 8 pounds after one year.
Studies show "the benefits are clear for patients," said Khoso Baluch, group brand leader for diabetes and urology at Lilly. “The drug could be useful to the 3 million to 4 million Americans who take oral diabetes medications but still aren't controlling their blood-sugar, he said.”
The drug could be on the U.S. market by mid-2005 if the Food and Drug Administration approves it in the normal review period of about a year.
For more information see: http://www.indystar.com/articles/3/159049-5493-031.html
Studies show "the benefits are clear for patients," said Khoso Baluch, group brand leader for diabetes and urology at Lilly. “The drug could be useful to the 3 million to 4 million Americans who take oral diabetes medications but still aren't controlling their blood-sugar, he said.”
The drug could be on the U.S. market by mid-2005 if the Food and Drug Administration approves it in the normal review period of about a year.
For more information see: http://www.indystar.com/articles/3/159049-5493-031.html